Glucocerebrosidase mutations in a Serbian Parkinson's disease population

European Journal of Neurology

Volumn 20, Issue 2, 2013, Pages 402-405

  Kumar, K R ^a,b   Ramirez, A ^a,c   Gobel A ^a   Kresojevic N ^d   Svetel, M ^d   Lohmann, K ^a   M Sue, C ^b   Rolfs, A ^e   Mazzulli, J R ^f   Alcalay, R N ^g   Krainc, D ^f   Klein, C ^a   Kostic, V ^d   Grunewald A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF ROSTOCK   (Germany)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g Columbia University ^*  (United States)

Author keywords

Gaucher disease; GBA; Glucocerebrosidase; Parkinson's disease; Serbian

Indexed keywords

GLUCOSYLCERAMIDASE; LEVODOPA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GAUCHER DISEASE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SERBIA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSYLCERAMIDASE; HUMANS; JEWS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; SERBIA;

EID: 84872386771     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03817.x     Document Type: Article

References (13)

1. Beutler E, Gelbart T, Scott CR. Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 2005; 35: 355-364.
2. Lesage S, Anheim M, Condroyer C, et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in European with Parkinson's disease. Hum Mol Genet 2011; 20: 202-210.
3. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. New Eng J Med 2009; 361: 1651-1661.
4. Toft M, Pielsticker L, Ross OA, Aasly JO, Farrer MJ. Glucocerebrosidase gene mutations and Parkinson disease in the Norweigan population. Neurology 2006; 66: 415-417.
5. Rodríguez-Marí A, Díaz-Font A, Chabás A, Pastores GM, Grinberg D, Vilageliu L. New insights into the origin of the gaucher disease-causing mutation N370S: extended haplotype analysis using the 5GC3.2, 5470 G/A, and ITG6.2 polymorphisms. Blood Cells Mol Dis 2001; 27: 950-959.
6. Diaz GA, Gelb BD, Risch N, et al. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. Am J Hum Genetics 2000; 66: 1821-1832.
7. Cormand B, Grinberg D, Gort L, Chabás A, Vilageliu L. Molecular analysis and clinical findings in the spanish gaucher disease population: putative haplotype of the N370S ancestral chromosome. Hum Mutat 1998; 11: 295-305.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
9. Santamaria R, Michelakakis H, Moraitou M, et al. Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H;H255Q] double mutant allele. Hum Mutat 2008; 29: E58-67.
10. Gan-Or Z, Giladi N, Orr U. Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. Brain 2009; 132: e125.
11. Bras J, Paisan-Ruiz C, Guerreiro R, et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol Aging 2009; 30: 1515-1517.
12. Machaczka M, Rucinska M, Skotnicki AB, Jurczak W. Parkinson's syndrome preceding clinical manifestation of Gaucher's disease. Am J Hematol 1999; 61: 216-217.
13. Anheim M, Elbaz A, Lesage S, et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012; 78: 417-420.